Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS), as a new surgical method, brings hope to patients who cannot tolerate extensive liver resection because of the low future liver remnant volume after the conventional resection technique. From the time this method was proposed, it has been favored by surgical scientists, and its improvements are continuously being made during practice. Initial results showed a relatively high incidence of complications and death of ALPPS. Recently, with the development of techniques, zero mortality has been reported. However, the long-term oncological result of ALPPS is still unknown. Here, the authors, based on literature review, address the application of this technique.